Curaxis Pharmaceutical Corporation Management to Meet With Shareholders
07. November 2011 08:30 ET
|
Curaxis Pharmaceutical Corporation
RALEIGH, N.C., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Timothy R. Wright, Chairman and Interim Chief Executive Officer of Curaxis Pharmaceutical Corporation ("Curaxis" or the "Company') (OTCQB:CURX),...
Curaxis Pharmaceutical Corporation Management Working Through Transition Phase and Evaluating Alternatives
17. August 2011 08:15 ET
|
Curaxis Pharmaceutical Corporation
RALEIGH, N.C., Aug. 17, 2011 (GLOBE NEWSWIRE) -- Timothy R. Wright, Chairman and Interim Chief Executive Officer of Curaxis Pharmaceutical Corporation ("Curaxis" or the "Company") (OTCQB:CURX)...
Curaxis Pharmaceutical Corporation Chief Executive Officer Comments on Recent NIH Research
10. Mai 2011 14:14 ET
|
Curaxis Pharmaceutical Corporation
SWAMPSCOTT, Mass., May 10, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corporation (OTCBB:CURX) ("Curaxis" or the "Company"), commented...
Curaxis' Memryte Named One of the Top 100 Drugs in Development Today by R&D Directions
05. Mai 2011 02:30 ET
|
Curaxis Pharmaceutical Corporation
SWAMPSCOTT, Mass., May 5, 2011 (GLOBE NEWSWIRE) -- Curaxis Pharmaceutical Corporation (OTCQB:CURX) ("Curaxis" or the "Company") announced that its lead drug hormone product for Alzheimer's disease,...
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Prana Research
24. März 2011 04:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., March 24, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCBB:CURX) (Frankfurt:8CX), commented today on recent...
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent New York Times Article "Drug Firms Face Billions in Losses in '11 as Patents End"
10. März 2011 08:30 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., March 10, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt: 8CX), commented today on an article by...
Curaxis Pharmaceutical Corp. to Meet With Ticino Business Development Office in Lugano, Switzerland
14. Februar 2011 02:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 14, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt:8CX), announced that Curaxis management...
Curaxis Pharmaceutical Corp. Announces New Listing on the Frankfurt Stock Exchange
09. Februar 2011 02:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCQB:CURX) (Frankfurt:8CX), today announced Curaxis' new...
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Alzheimer's Association Report
07. Februar 2011 02:00 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCBB:CURX), commented today on a new report by the Alzheimer's...
Curaxis Pharmaceutical Management on Roadshow in Europe to Access Capital & Pursue Strategic Partners
03. Februar 2011 08:30 ET
|
Curaxis Pharmaceutical Corporation
DURHAM, N.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp (OTCBB:CURX), confirmed today that Curaxis Management will be in...